Stroke Care Measures
|
Brief Explanation of Treatment
|
| Treatment to prevent blot clots |
This measure tells how often stroke patients unable to walk within 48 hours receive treatment to prevent blood clots
|
|
Antithrombotics given within 48 hours
|
Antithrombotics are drugs that reduce the risk of recurrent stroke caused by blood flow blockages from clots.
|
|
Antithrombotics given on discharge
|
Antithrombotics are drugs that reduce the risk of recurrent stroke caused by blood flow blockages from clots.
|
|
Anticoagulants given for atrial fibrillation
|
Atrial fibrillation is a common heart arrhythmia and risk factor for stroke. Anticoagulation can be effective in preventing recurrent stroke in patients with atrial fibrillation when there are no medication contraindications.
|
|
Tissue plasminogen activator (t-PA), a clot-busting drug, considered
|
Certain patients, meeting strict criteria for the administration of this drug, within 3 hours of symptom onset, have been found to experience more rapid recovery and improved treatment outcomes.
|
|
Lipid-lowering drugs given for high lipid values
|
Elevated lipids are a risk factor for stroke which can be reduced through treatment with a lipid-lowering drug(s).
|
|
Screened for ability to swallow
|
Problems with swallowing can be identified through swallow screening. Screening prior to any oral intake reduces the risk of food and/or fluid entering the respiratory system.
|
|
Stroke education provided
|
Patient/family education should include information about stroke (its causes, treatment and risk factors) as well as desirable lifestyle modification.
|
|
Given smoking cessation advice
|
Smoking nearly doubles the risk of non-hemorrhagic stroke and is an alterable risk factor.
|
|
Plan for rehabilitation considered
|
Effective rehabilitation, initiated early following stroke, can in many instances, enhance recovery, prevent complications and minimize long-term disability
|